Risk factors of treatment interruptions among drug-sensitive and drug-resistant pulmonary tuberculosis patients - A study from South Delhi, New Delhi, India
- 3 January 2024
- journal article
- research article
- Published by Elsevier in Indian Journal of Tuberculosis
- Vol. 71, S72-S76
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Variations in rifampicin and isoniazid resistance associated genetic mutations among drug naïve and recurrence cases of pulmonary tuberculosisInternational Journal of Infectious Diseases, 2021
- Detect–Treat–Prevent–Build: Strategy for TB elimination in India by 2025Indian Journal of Community Medicine, 2018
- Analysis of treatment outcome in multi-drug resistant tuberculosis patients treated under programmatic conditionsInternational Journal of Research in Medical Sciences, 2017
- Effects of Treatment Interruption Patterns on Treatment Success Among Patients With Multidrug-Resistant Tuberculosis in Armenia and AbkhaziaThe Journal of Infectious Diseases, 2014
- Current status of timing of treatment interruption and pattern of default among tuberculosis patients on directly observed treatmentJournal of Dr. NTR University of Health Sciences, 2013
- Risk factors for tuberculosis treatment failure, default, or relapse and outcomes of retreatment in MoroccoBMC Public Health, 2011
- Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosisBMC Infectious Diseases, 2011
- Mortality and failure among tuberculosis patients who did not complete treatment in Vietnam: a cohort studyBMC Public Health, 2007
- An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatmentBMC Public Health, 2004
- Tuberculosis in HIV-infected patients: a comprehensive reviewClinical Microbiology and Infection, 2004